Considering Changes in the Recommended Human Chorionic Gonadotropin Monitoring After Molar Evacuation

Neil S Horowitz1, Ross S Berkowitz, Kevin M Elias

  • 1From the New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts;

Obstetrics and Gynecology
|December 7, 2019
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos